Biltmore Family Office, LLC Bristol Myers Squibb CO Transaction History

Biltmore Family Office, LLC

$566 Million
Q3 2024

A detailed history of Biltmore Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Biltmore Family Office, LLC holds 10,292 shares of BMY stock, worth $576,969. This represents 0.09% of its overall portfolio holdings.

Number of Shares

10,292

Previous 10,142 1.48%

Holding current value

$576,969

Previous $421,000 26.37%

% of portfolio

0.09%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $5,948 - $7,762	150 Added 1.48%	10,292 $532,000
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $40,250 - $52,990	-1,000 Reduced 8.98%	10,142 $421,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $56,527 - $67,453	-1,166 Reduced 9.47%	11,142 $571,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $2,026 - $2,265	-35 Reduced 0.28%	12,308 $714,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $47,655 - $52,913	-748 Reduced 5.71%	12,343 $789,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $66,498 - $75,424	1,012 Added 8.38%	13,091 $907,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $92,242 - $109,228	1,347 Added 12.55%	12,079 $868,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $14 - $8,529	-111 Reduced 1.02%	10,732 $763,000
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $56,425 - $62,144	-777 Reduced 6.69%	10,843 $841,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $61,480 - $73,720	-1,000 Reduced 7.92%	11,620 $855,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $107,260 - $125,040	2,000 Added 18.83%	12,620 $787,000
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $17,768 - $19,349	-287 Reduced 2.63%	10,620 $710,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $33,527 - $37,708	-565 Reduced 4.93%	10,907 $694,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $119,175 - $135,047	2,064 Added 21.94%	11,472 $717,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $29,835 - $43,357	643 Added 7.34%	9,408 $524,000
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $1.16 Million - $1.51 Million	-23,600 Reduced 72.92%	8,765 $563,000
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $997,695 - $1.18 Million	23,327 Added 258.1%	32,365 $1.64 Million
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $1.53 Million - $1.69 Million	-34,250 Reduced 79.12%	9,038 $410,000
Q1 2019 Apr 12, 2019	SELL	$45.12 - $53.8 $2,256 - $2,690	-50 Reduced 0.12%	43,288 $2.07 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $5,997 - $7,777	123 Added 0.28%	43,338 $2.25 Million
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $9,853 - $12,281	-195 Reduced 0.45%	43,215 $2.39 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $2.6 Million - $2.84 Million	43,410	43,410 $2.66 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Bristol Myers Squibb CO Transaction History